Liquidia (LQDA) Other Accumulated Expenses (2019 - 2026)
Liquidia (LQDA) posted quarterly Other Accumulated Expenses of $11.3 million for Q1 2026, up 119.73% year-over-year from $5.2 million in Q1 2025, and up 34.83% quarter-over-quarter from $8.4 million in Q4 2025.
Liquidia (LQDA) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
Liquidia's Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $11.3 million for Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 119.73% year-over-year to $11.3 million; the TTM figure through Mar 2026 stood at $11.3 million (up 119.73% YoY), while the FY2025 annual figure was $8.4 million, up 96.65% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $11.3 million, up from $8.4 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $11.3 million in Q1 2026, with the low at $903000.0 in Q4 2022.
- The 5-year median for Other Accumulated Expenses is $4.3 million (2024), against an average of $4.3 million.
- The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses tumbled 73.47% in 2023, then jumped 304.44% in 2024.
- Liquidia's Other Accumulated Expenses stood at $903000.0 in 2022, then jumped by 116.39% to $2.0 million in 2023, then surged by 118.63% to $4.3 million in 2024, then jumped by 96.65% to $8.4 million in 2025, then jumped by 34.83% to $11.3 million in 2026.
- Business Quant data shows LQDA's Other Accumulated Expenses at $11.3 million in Q1 2026, $8.4 million in Q4 2025, and $7.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Liquidia | 6.36 Bn | 6.08 Bn | 160.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.10 Mn |
| Mar 31, 2026 | 11.33 Mn |
| Dec 31, 2025 | 8.40 Mn |
| Sep 30, 2025 | 7.47 Mn |
| Jun 30, 2025 | 10.01 Mn |
| Mar 31, 2025 | 5.16 Mn |
| Dec 31, 2024 | 4.27 Mn |
| Sep 30, 2024 | 4.25 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Mar 31, 2024 | 4.64 Mn |
| Dec 31, 2023 | 1.95 Mn |
| Sep 30, 2023 | 2.38 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 903,000.00 |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Mar 31, 2022 | 4.33 Mn |
| Dec 31, 2021 | 1.67 Mn |
| Sep 30, 2021 | 2.32 Mn |